National Cancer Institute of Canada Clinical Trials Group MAR3 trial: Evaluation of exemestane to prevent breast cancer in postmenopausal women

Paul E. Goss, Harriet Richardson, Rowan Chlebowski, Dianne Johnston, Gloria E. Sarto, Elizabeth Maunsell, James N. Ingle, José E. Alés-Martinez

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)895-900
Number of pages6
JournalClinical breast cancer
Volume7
Issue number11
DOIs
StatePublished - Dec 2007

Keywords

  • Aromatase inhibitors
  • Estrogen receptor
  • Selective estrogen receptor modulators

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Goss, P. E., Richardson, H., Chlebowski, R., Johnston, D., Sarto, G. E., Maunsell, E., Ingle, J. N., & Alés-Martinez, J. E. (2007). National Cancer Institute of Canada Clinical Trials Group MAR3 trial: Evaluation of exemestane to prevent breast cancer in postmenopausal women. Clinical breast cancer, 7(11), 895-900. https://doi.org/10.3816/CBC.2007.n.057